The Platelet Destruction Site in Thrombocytopenic Purpuras
暂无分享,去创建一个
[1] A. F. Abrahamsen. THE EFFECT OF EDTA AND ACD ON THE RECOVERY AND SURVIVAL OF CR51-LABELLED BLOOD PLATELETS. , 2009, Scandinavian journal of haematology.
[2] N. Ardaillou,et al. Survival and distribution of platelets. , 1965, Minerva nucleare.
[3] S. Ebbe,et al. COMPARATIVE STUDIES OF PLATELET SURVIVAL BY DIFFERENT METHODS IN THE RABBIT. , 1965, Blood.
[4] R. Aster,et al. PLATELET SEQUESTRATION IN MAN. I. METHODS. , 1964, The Journal of clinical investigation.
[5] H. Lander,et al. The Behaviour of Infused Human Platelets During the First Twenty‐Four Hours After Infusion , 1964, British journal of haematology.
[6] N. Ardaillou,et al. SURVIVAL OF RADIOCHROMIUM-LABELED PLATELETS IN THROMBOCYTOPENIAS. , 1963, Blood.
[7] H. Lander,et al. THE LABELLING OF HUMAN PLATELETS WITH RADIOCHROMATE. , 1963, The Australian journal of experimental biology and medical science.
[8] P. Castaldi,et al. STUDIES OF THE LIFE SPAN AND FATE OF PLATELETS. , 1963, Australasian annals of medicine.
[9] J. Walker,et al. Infection following splenectomy in childhood. , 1962, Lancet.
[10] T. McDonald,et al. Response of rat megakaryocytes and platelets to bleeding. , 1962, Acta haematologica.
[11] J. Dausset,et al. Study of leukopenias and thrombocytopenias by the direct antiglobulin consumption test on leukocytes and/or platelets. , 1961, Blood.
[12] D. C. Campbell,et al. Idiopathic thrombocytopenic purpura. Treatment in adults. , 1961, Archives of internal medicine.
[13] F. Gardner,et al. The thrombocytopenic effect of sustained high-dosage prednisone therapy in thrombocytopenic purpura. , 1961, The New England journal of medicine.
[14] M. C. Meyers. RESULTS OF TREATMENT IN 71 PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA , 1961, The American journal of the medical sciences.
[15] A. Ley,et al. Studies on platelet life span and platelet depots by use of DFP-32. , 1961, The Journal of laboratory and clinical medicine.
[16] G. Barnett,et al. Reclassification of the thrombocytopenias by the Cr51-labeling method for measuring platelet life span. , 1961, The New England journal of medicine.
[17] J. Tullis. The role of leukocyte and platelet antibody tests in management of diverse clinical disorders. , 1961, Annals of internal medicine.
[18] G. Barnett,et al. Reclassification of the thrombocytopenias by the Cr51-labeling method for measuring platelet life span. , 1961, The New England journal of medicine.
[19] B. Bouroncle,et al. IDIOPATHIC AND SECONDARY THROMBOCYTOPENIC PURPURA: CLINICAL STUDY AND EVALUATION OF 381 CASES OVER A PERIOD OF 28 YEARS , 1960 .
[20] W. Scharfman,et al. Idiopathic thrombocytopenic purpura: an evaluation of the patterns of response to various therapies. , 1960, Journal of the American Medical Association.
[21] A. Carpenter,et al. Treatment of idiopathic thrombocytopenic purpura. , 1959, Journal of the American Medical Association.
[22] W. Dameshek. TREATMENT of idiopathic thrombocytopenic purpura. , 1960, British medical journal.
[23] F. Gardner,et al. Survival of blood platelets labeled with chromium. , 1958, The Journal of clinical investigation.
[24] W. Dameshek. Systemic lupus erythematosus: a complex auto-immune disorder. , 1958, Annals of internal medicine.
[25] W. Crosby,et al. Studies of platelet survival by tagging in vivo with p32. , 1957, The Journal of laboratory and clinical medicine.
[26] M. Erlandson,et al. Hazard of severe infections in splenectomized infants and children. , 1957, The American journal of medicine.
[27] J. Cohen,et al. Determination of the life span of human blood platelets using labelled diisopropylfluorophosphonate. , 1956, The Journal of clinical investigation.
[28] J. B. Chatterjea,et al. Studies on platelets. V. Observations on the removal by the pulmonary circulation of platelets injected into patients with idiopathic thrombocytopenic purpura. , 1952, The Journal of laboratory and clinical medicine.